Supplementary Figure S3 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Figure S3. Patient-level concentration profile of bintrafusp alfa at Day 1 postdose.
Supplementary Figure S3 from Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer | Synapse